No 98% chance. Hantavirus vaccine in 2026? — live odds, $140K volume, resolves 2027-01-01. Trade on PredyX.
Current outcome probabilities for Hantavirus vaccine in 2026?
Outcome
Probability
24h change
Volume
Yes
2%
0.0%
—
No
98%
0.0%
—
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
What are the current odds for Hantavirus vaccine in 2026? ?
As of today, Yes at 2%, No at 98%, based on live Polymarket trading data.
When does "Hantavirus vaccine in 2026? " resolve?
This market resolves on January 1, 2027.
How much has been traded on Hantavirus vaccine in 2026? ?
Total trading volume is $139,958, with $53,324 in liquidity.
How do I trade "Hantavirus vaccine in 2026? "?
You can trade this Polymarket prediction market directly from your browser on PredyX — a non-custodial trading terminal with live odds, limit orders, and copy trading.
